• 中文
    • 登錄
    • 聯系我們
    ×
    目錄產品 » 抗體產品 » 一抗 » 抗獨特型(Anti-idiotype)抗體 » Anti-Daratumumab Antibody (11F2), mAb, Mouse
    Anti-Daratumumab Antibody (11F2), MAb, Mouse

    ELISA binding of Anti-Daratumumab Antibody (11F2) (GenScript, A01996-40) with Daratumumab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
    Coating antigen: Daratumumab, 1 μg/ml.
    Anti-Daratumumab Antibody (11F2) (GenScript, A01996-40) dilutions start from 1,000 ng/ml.
    EC50= 17.40 ng/ml.

    Anti-Daratumumab Antibody (11F2), MAb, Mouse

    Standard curve of Daratumumab Sandwich ELISA. The Daratumumab Sandwich ELISA assay is developed by using Anti-Daratumumab Antibody (11F2), mAb, Mouse (GenScript, A01996) and Anti-Daratumumab Antibody (6A3) (Genscript, A01997-40) as the capture and detection antibodies, respectively.
    In this ELISA assay, Anti-Daratumumab Antibody (6A3) (GenScript, A01997-40) was labeled with Biotin. The sensitivity of detecting Daratumumab is up to 0.039 ng/ml.
    GenScript can provide customized conjugation services for this product per the customer's request.

    Anti-Daratumumab Antibody (11F2), mAb, Mouse

    The product is specific for Daratumumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody Genscript, A01997 Anti-Daratumumab Antibody (6A3).
    A01996
    ¥990

    聯系我們
    Specificity The product is specific for Daratumumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody Genscript, A01997 Anti-Daratumumab Antibody (6A3).
    Host Species Mouse
    Immunogen Daratumumab
    Conjugate Unconjugated

    Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
    Application Recommended Usage
    ELISA 0.01-0.1 μg/ml

    Form Lyophilized
    Storage Buffer Lyophilized with PBS, pH 7.4, containing 0.02% sodium azide.
    Reconstitution Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/ml.
    Storage Instructions The lyophilized product remains stable up to 1 year at -20 °C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 °C or for up to 12 months at -20 °C or below. Avoid repeated freezing and thawing cycles.
    Purification Protein A affinity column
    Isotype Mouse IgG1
    Clonality Monoclonal
    Clone ID 11F2
    Note GenScript can customize this product per customer's request including product size, buffer components, etc.

    • Anti-Daratumumab Antibody (11F2), MAb, Mouse
    • Anti-Daratumumab Antibody (11F2), MAb, Mouse

      ELISA binding of Anti-Daratumumab Antibody (11F2) (GenScript, A01996-40) with Daratumumab. While the antibody does not recognize the human IgG Fc fragment (data not shown).
      Coating antigen: Daratumumab, 1 μg/ml.
      Anti-Daratumumab Antibody (11F2) (GenScript, A01996-40) dilutions start from 1,000 ng/ml.
      EC50= 17.40 ng/ml.

    • Anti-Daratumumab Antibody (11F2), MAb, Mouse
    • Anti-Daratumumab Antibody (11F2), MAb, Mouse

      Standard curve of Daratumumab Sandwich ELISA. The Daratumumab Sandwich ELISA assay is developed by using Anti-Daratumumab Antibody (11F2), mAb, Mouse (GenScript, A01996) and Anti-Daratumumab Antibody (6A3) (Genscript, A01997-40) as the capture and detection antibodies, respectively.
      In this ELISA assay, Anti-Daratumumab Antibody (6A3) (GenScript, A01997-40) was labeled with Biotin. The sensitivity of detecting Daratumumab is up to 0.039 ng/ml.
      GenScript can provide customized conjugation services for this product per the customer's request.


    Target Background Daratumumab (Darzalex) is a human monoclonal antibody that is approved by the U.S. Food and Drug Administration for the trea?ent of multiple myeloma. Daratumumab binds to CD38 on multiple myeloma cells and induces cells to apoptose via antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity.GenScript Anti-Daratumumab Antibody (11F2), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Daratumumab.
    Synonyms Mouse monoclonal antibody to Darzalex

    For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


    国产小受呻吟cv视频在线观看